Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause
Genitourinary syndrome of menopause (GSM) and vulvovaginal atrophy (VVA) are common menopause-related disorders. Nonhormonal treatments are first-line, while topical estrogen is the gold standard, but not suitable for cancer survivors. This study evaluated nonablative diode laser treatment in sexually active women with GSM who cannot use or refuse estrogen therapy. Using a Leonardo Dual diode laser, 26 patients received three monthly treatments. Significant improvements were observed in the Vaginal Health Index (VHI), symptom severity (VAS score), and sexual function (FSFI-19). No adverse effects were reported, and 73.1% of patients noted symptom improvement.
